Company / Total Assets
AVADEL PHARMACEUTICALS PLC Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$164.2M
FY2024
5-year range
$132.8M / $311.6M
FY2020-FY2024
Trend
-0.3%
vs FY2023
Sector context
#202 of 214
Health Care
What the data says
Among 214 Health Care companies, AVADEL PHARMACEUTICALS PLC is in the bottom 6% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $133M in FY2022 to $312M in FY2020.
Based on SEC 10-K filings.
$164M in FY2024 with a 5-year CAGR of +1.6%.
Improved from $133M to $164M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -12.7%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 214This company $164.2M Sector average $7.5B
▼
-97.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2024, total assets decreased 0.3% year-over-year.
- Ranks #202 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $164.2M | -0.3% |
| FY2023 | $164.7M | +24.0% |
| FY2022 | $132.8M | -46.3% |
| FY2021 | $247.3M | -20.7% |
| FY2020 | $311.6M | +105.8% |
| FY2019 | $151.4M | -20.4% |
| FY2018 | $190.3M | -24.9% |
| FY2017 | $253.3M | +3.2% |
| FY2016 | $245.5M | +14.1% |
| FY2015 | $215.1M | +23.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026